Search Results 1901-1910 of 13991 for Birth Control Palette
UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...
The primary purpose of this study is to assess the safety and tolerability of RP-6306 with FOLFIRI in patients with eligible advanced solid tumors, ...
She is also conducting a large population-based study using 10,000 Mayo Clinic Biobank samples to preemptively sequence 76 pharmacogenes and add this ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
Research · Mayo researchers identify mechanism of oncogene action in lung cancer featured image · Women's Wellness: Vaginal microbes and endometrial cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!